G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, N. Melchionda, Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50(8), 1844–1850 (2001)

Article  CAS  PubMed  Google Scholar 

E. Muzurović, D.P. Mikhailidis, C. Mantzoros, Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119, 154770 (2021)

Article  PubMed  Google Scholar 

G. Targher, C.P. Day, E. Bonora, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363(14), 1341–1350 (2010)

Article  CAS  PubMed  Google Scholar 

S.A. Harrison, P. Bedossa, C.D. Guy, J.M. Schattenberg, R. Loomba, R. Taub, D. Labriola, S.E. Moussa, G.W. Neff, M.E. Rinella et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390(6), 497–509 (2024)

Article  PubMed  Google Scholar 

G. Targher, A.P. Rossi, G.A. Zamboni, F. Fantin, A. Antonioli, F. Corzato, C. Bambace, R. Pozzi Mucelli, M. Zamboni, Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J. Endocrinol. Invest. 35(8), 748–753 (2012)

CAS  PubMed  Google Scholar 

J. Ko, I.R. Sequeira, L. Skudder-Hill, J. Cho, S.D. Poppitt, M.S. Petrov, Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis. Diabetologia 66(1), 190–200 (2023)

Article  CAS  PubMed  Google Scholar 

M. Zhang, Z. Shi, C. Wu, F. Yang, T. Su, X. Jing, J. Shi, H. Ren, L. Jiang, Y. Jiang et al. Cushing syndrome is associated with gut microbial dysbiosis and cortisol-degrading bacteria. J. Clin. Endocrinol. Metab. 109(6), 1474–1484 (2024)

Article  PubMed  Google Scholar 

V. Favero, C. Eller-Vainicher, V. Morelli, E. Cairoli, A.S. Salcuni, A. Scillitani, S. Corbetta, S.D. Casa, G. Muscogiuri, L. Persani et al. Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 109(2), e623–e632 (2024)

Article  PubMed  Google Scholar 

A.X. Chen, A. Radhakutty, S.M. Drake, A. Kiu, C.H. Thompson, M.G. Burt, Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 109(3), e1020–e1028 (2024)

Article  PubMed  Google Scholar 

M.K. Auer, G.K. Stalla, M.R. Stieg, Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. Pituitary 19(5), 461–471 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Pasquali, F. Casanueva, M. Haluzik, L. van Hulsteijn, S. Ledoux, M.P. Monteiro, J. Salvador, F. Santini, H. Toplak, O.M. Dekkers, European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur. J. Endocrinol. 182(1), G1–G32 (2020)

Article  CAS  PubMed  Google Scholar 

V. Favero, A. Cremaschi, A. Falchetti, A. Gaudio, L. Gennari, A. Scillitani, F. Vescini, V. Morelli, C. Aresta, I. Chiodini, Management and medical therapy of mild hypercortisolism. Int. J. Mol. Sci. 22(21), 11521 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Fassnacht, S. Tsagarakis, M. Terzolo, A. Tabarin, A. Sahdev, J. Newell-Price, I. Pelsma, L. Marina, K. Lorenz, I. Bancos et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189(1), G1–G42 (2023)

Article  PubMed  Google Scholar 

Q.M. Anstee, T.L. Berentzen, L.M. Nitze, M. Jara, A.B. Jensen, M.S. Kjær, K.K. Mangla, J.M. Tarp, K. Khunti, Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study. Lancet Reg. Health Eur. 36, 100780 (2024)

Article  PubMed  Google Scholar 

American DAPP: 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care 47(1), S20–S42 (2024)

K.J. Preacher, A.F. Hayes, Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 40(3), 879–891 (2008)

Article  PubMed  Google Scholar 

J. Westerbacka, H. Yki-Jarvinen, S. Vehkavaara, A.M. Hakkinen, R. Andrew, D.J. Wake, J.R. Seckl, B.R. Walker, Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J. Clin. Endocrinol. Metab. 88(10), 4924–4931 (2003)

Article  CAS  PubMed  Google Scholar 

R.E. Goldstein, D.H. Wasserman, O.P. McGuinness, D.B. Lacy, A.D. Cherrington, N.N. Abumrad, Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am. J. Physiol. 264(1 Pt 1), E119 (1993)

CAS  PubMed  Google Scholar 

R. Ortiz, B. Kluwe, J.B. Odei, J.B. Echouffo Tcheugui, M. Sims, R.R. Kalyani, A.G. Bertoni, S.H. Golden, J.J. Joseph, The association of morning serum cortisol with glucose metabolism and diabetes: the Jackson Heart Study. Psychoneuroendocrinology 103, 25–32 (2019)

Article  CAS  PubMed  Google Scholar 

S. Dinneen, A. Alzaid, J. Miles, R. Rizza, Effects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDM. Am. J. Physiol. 268(4 Pt 1), E595–E603 (1995)

CAS  PubMed  Google Scholar 

M.E. Cornide Petronio, E. Bujaldon, M. Mendes Braz, C.G. Avalos De León, M.B. Jiménez Castro, A.I. Álvarez Mercado, J. Gracia Sancho, J. Rodés, C. Peralta, The impact of cortisol in steatotic and non-steatotic liver surgery. J. Cell Mol. Med. 21(10), 2344–2358 (2017)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F. Ferraù, M. Korbonits, Metabolic comorbidities in Cushing’s syndrome*. Eur. J. Endocrinol. 173(4), M133–M157 (2015)

Article  PubMed  Google Scholar 

X. Sun, M. Feng, L. Lu, Z. Zhao, X. Bao, K. Deng, Y. Yao, H. Zhu, R. Wang. Lipid abnormalities in patients with Cushing’s disease and its relationship with impaired glucose metabolism. Front. Endocrinol. 11, 600323 (2021)

S.A. Polyzos, G. Targher, Role of glucocorticoids in metabolic dysfunction-associated steatotic liver disease. Curr. Obes. Rep. 13(2), 242–255 (2024)

Article  PubMed  PubMed Central  Google Scholar 

Y. Liang, M.C. Osborne, B.P. Monia, S. Bhanot, L.M. Watts, P. She, S.O. DeCarlo, X. Chen, K. Demarest, Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice. Metabolism 54(7), 848–855 (2005)

Article  CAS  PubMed  Google Scholar 

C. Beaupere, A. Liboz, B. Fève, B. Blondeau, G. Guillemain, Molecular mechanisms of glucocorticoid-induced insulin resistance. Int. J. Mol. Sci. 22(2), 623 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B. Friedmann, J.E.H. Goodman, S. Weinhouse, Effects of glucose feeding, cortisol, and insulin on liver glycogen synthesis in the rat. Endocrinology 81(3), 486 (1967)

Article  CAS  PubMed  Google Scholar 

R.M. de Guia, Stress, glucocorticoid signaling pathway, and metabolic disorders. Diab. Metab. Syndr. Clin. Res. Rev. 14(5), 1273–1280 (2020)

Google Scholar 

M.O. Weickert, A.F.H. Pfeiffer, Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49(8), 1732–1741 (2006)

Article  CAS  PubMed  Google Scholar